The Multi-Cluster/Sector Initial Rapid Assessment (MIRA) is a joint needs assessment tool that can be used in sudden onset emergencies, including IASC System-Wide Level 3 Emergency Responses (L3 Responses).
Disaster Recovery Toolkit
Psycho-Social Rehabilitation and Occupational Integration of Child Survivors of Trafficking and Other Worst Forms of Child Labour |
Over 244,000 displaced people remain in camps or camp-like situations in Kachin, Shan, Rakhine
and Kayin states. Children make up at least 50 per cent of this population, while women and„Myanmar: 2019 Humanitarian Needs Overview - Myanmar“. ReliefWeb. Zugegriffen 4. Januar 2019. https://reliefw...eb.int/report/myanmar/myanmar-2019-humanitarian-needs-overview.
children together make up about 77 per cent. This includes approximately 97,000 people in
Kachin, 8,800 in Shan and 10,300 in Kayin who remain displaced as a result of the armed conflict.
It also includes about 128,000 people in Rakhine, the vast majority of whom are stateless, who
were displaced as a result of the violence in 2012.
more
UNICEF Strategic Plan 2018-2021. Draft Theory of Change Paper
Disaster Recovery Toolkit
This manual is for the beginner/intermediate and advanced EHA courses run by Channel Research on behalf of ALNAP. It is supported by a course specific set of case studies and exercises and by a bibliography of evaluation references
A thesis submitted for the Degree of Master of Theology at the South African Theological Seminary
Amoris laetitia: Post-Synodal Apostolic Exhortation on love in the family (19 March 2016)
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future... supply security. In 2021, the AU set a target to produce and supply more than 60% of the vaccine doses on the continent by 2040.
In the last 18 months alone, more than 30 new African manufacturing projects have been announced and estimates indicate that the African vaccine market across all existing and projected novel products could range between US$ 2.8 billion and US$ 5.6 billion by 2040*, demonstrating the potential for a thriving regional industry to emerge.
more